Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOrion Biotech Opportunities Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/29/2023 | Q4 2022 | $0.49 | $0 | |||
| 11/09/2022 | Q3 2022 | $0.08 | $0 | |||
| 08/12/2022 | Q2 2022 | $0.16 | $0 | |||
| 05/10/2022 | Q1 2022 | $196,178.00 | $0 | |||
| 03/24/2022 | Q4 2021 | -$0.33 | $0 | |||
| 11/12/2021 | Q3 2021 | $0.45 | $0 | |||
| 08/12/2021 | Q2 2021 | -$0.41 | $0 | |||
| 06/28/2021 | Q1 2021 | $0.00 | $0 |
Orion Biotech Opportunities Corp. Earnings: FAQ's
When is Orion Biotech Opportunities Corp.'s earnings date?
Orion Biotech Opportunities Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 30th, 2022 based off last year's report dates.
How can I listen to Orion Biotech Opportunities Corp.'s earnings conference
call?
The conference call for Orion Biotech Opportunities Corp.'s latest earnings report can be listened to online.
How can I read Orion Biotech Opportunities Corp.'s conference call transcript?
The conference call transcript for Orion Biotech Opportunities Corp.'s latest earnings report can be read online.
How much profit does Orion Biotech Opportunities Corp. generate each year?
Orion Biotech Opportunities Corp. (:ORIAW) has a recorded net income of $0. Orion Biotech Opportunities Corp. has generated $0.92 earnings per share over the last four quarters.
What is Orion Biotech Opportunities Corp.'s price-to-earnings ratio?
Orion Biotech Opportunities Corp. (:ORIAW) has a price-to-earnings ratio of 11.11 and price/earnings-to-growth ratio is 0.11.